Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828237 | PMC |
| http://dx.doi.org/10.1007/s11239-016-1373-0 | DOI Listing |
Publication Analysis
Top Keywords
erratum pcsk9
4
pcsk9 inhibitors
4
inhibitors prevention
4
prevention cardiovascular
4
cardiovascular disease
4
erratum
1
inhibitors
1
prevention
1
cardiovascular
1
disease
1
Similar Publications
Correction: Circulating levels of PCSK9, ANGPTL3 and lp(a) in stage III breast cancers.
BMC Cancer
November 2024
Faculty of Medicine, Laval University, Quebec City, QC, Canada.
Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum.
Ann Med Surg (Lond)
September 2024
[This corrects the article DOI: 10.1097/MS9.0000000000001601.
View Article and Find Full Text PDFCorrection to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis.
Adv Ther
May 2024
Department of Medicine, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!